论文信息 - An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels - 字舞流文

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels

P. Lockhart | L. Corben | J. Sarsero | A. Vogel | M. Delatycki | Trevor A. Mori | K. Croft | A. Churchyard | G. Rance | M. Ryan | Katherine J. Lee | B. Scheiber-Mojdehkar | G. Tai | E. Yiu | C. Stockley | M. Evans-Galea | R. Peverill | C. J. Lee | B. Sturm | M. Praschberger | B. Scheiber‐Mojdehkar | S. Stephenson | Trevor A. Mori | Monika Praschberger | Marguerite V. Evans-Galea